Wasnick, R.* ; Korfei, M.* ; Piskulak, K.* ; Henneke, I.* ; Wilhelm, J.* ; Mahavadi, P.* ; Dartsch, R.C.* ; von der Beck, D.* ; Koch, M.* ; Shalashova, I.* ; Weiss, A.R.* ; Klymenko, O.* ; Askevold, I.* ; Fink, L.* ; Witt, H.* ; Hackstein, H.* ; El Agha, E.* ; Bellusci, S.* ; Klepetko, W.* ; Königshoff, M. ; Eickelberg, O.* ; Schermuly, R.T.* ; Braun, T.* ; Seeger, W.* ; Ruppert, C.* ; Guenther, A.*
     
 
    
        
Notch1 induces defective epithelial surfactant processing and pulmonary fibrosis.
    
    
        
    
    
        
        Am. J. Respir. Crit. Care Med. 207, 283-299 (2023)
    
    
    
		
		
			
				Rationale: Although type II alveolar epithelial cells (AEC2s) are chronically injured in idiopathic pulmonary fibrosis (IPF), they contribute to epithelial regeneration in IPF. Objectives: We hypothesized that Notch signaling may contribute to AEC2 proliferation, dedifferentiation characterized by loss of surfactant processing machinery, and lung fibrosis in IPF. Methods: We applied microarray analysis, kinome profiling, flow cytometry, immunofluorescence analysis, western blotting, quantitative PCR, and proliferation and surface activity analysis to study epithelial differentiation, proliferation, and matrix deposition in vitro (AEC2 lines, primary murine/human AEC2s), ex vivo (human IPF-derived precision-cut lung slices), and in vivo (bleomycin and pepstatin application, Notch1 [Notch receptor 1] intracellular domain overexpression). Measurements and Main Results: We document here extensive SP-B and -C (surfactant protein-B and -C) processing defects in IPF AEC2s, due to loss of Napsin A, resulting in increased intra-alveolar surface tension and alveolar collapse and induction of endoplasmic reticulum stress in AEC2s. In vivo pharmacological inhibition of Napsin A results in the development of AEC2 injury and overt lung fibrosis. We also demonstrate that Notch1 signaling is already activated early in IPF and determines AEC2 fate by inhibiting differentiation (reduced lamellar body compartment, reduced capacity to process hydrophobic SP) and by causing increased epithelial proliferation and development of lung fibrosis, putatively via altered JAK (Janus kinase)/Stat (signal transducer and activator of transcription) signaling in AEC2s. Conversely, inhibition of Notch signaling in IPF-derived precision-cut lung slices improved the surfactant processing capacity of AEC2s and reversed fibrosis. Conclusions: Notch1 is a central regulator of AEC2 fate in IPF. It induces alveolar epithelial proliferation and loss of Napsin A and of surfactant proprotein processing, and it contributes to fibroproliferation.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        interstitial lung disease; diffuse parenchymal lung disease; lung surfactant; epithelial regeneration; idiopathic pulmonary fibrosis; Alveolar Type-ii; C-based Surfactant; Signaling Controls; Lung Development; Stem-cells; Differentiation; Pneumonitis; Expression; Quantification; Regeneration
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2023
    
 
    
        Prepublished im Jahr 
        0
    
 
    
        HGF-Berichtsjahr
        2023
    
 
    
    
        ISSN (print) / ISBN
        1073-449X
    
 
    
        e-ISSN
        1535-4970
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 207,  
	    Heft: 3,  
	    Seiten: 283-299 
	    Artikelnummer: ,  
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            American Thoracic Society
        
 
        
            Verlagsort
            25 Broadway, 18 Fl, New York, Ny 10004 Usa
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30202 - Environmental Health
    
 
    
        Forschungsfeld(er)
        Lung Research
    
 
    
        PSP-Element(e)
        G-503100-001
    
 
    
        Förderungen
        Lung Fibrosis Foundation Waldhof-Elgershausen
European Commission
German Ministry of Science and Education (German Center for Lung Research, DA DPLD Funds)
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2024-01-16